246 related articles for article (PubMed ID: 12085977)
1. Effect of nipradilol on silent myocardial ischemia and heart rate variability in chronic stable angina.
Takase B; Hikita H; Satomura K; Mastui T; Ohsuzu F; Kurita A
Cardiovasc Drugs Ther; 2002 Jan; 16(1):43-51. PubMed ID: 12085977
[TBL] [Abstract][Full Text] [Related]
2. Effect of nipradilol on silent myocardial ischemia, plasma beta-endorphin, and bradykinin in chronic stable angina.
Takase B; Kurita A; Uehata A; Hikita H; Nishioka T; Mitani H; Satomura K; Mizuno K; Nakamura H
Clin Cardiol; 1996 Jun; 19(6):477-82. PubMed ID: 8790952
[TBL] [Abstract][Full Text] [Related]
3. Effect of aprindine on heart rate variability indices in patients with ischemic heart disease.
Takase B; Uehata A; Nishioka T; Arakawa K; Satomura K; Ohsuzu F; Kurita A
Clin Cardiol; 1999 Feb; 22(2):107-12. PubMed ID: 10068848
[TBL] [Abstract][Full Text] [Related]
4. Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system.
Takase B; Hikita H; Uehata A; Satomura K; Kurita A; Nakamura H
Am Heart J; 1997 Nov; 134(5 Pt 1):945-54. PubMed ID: 9398108
[TBL] [Abstract][Full Text] [Related]
5. Day-to-day variability of the long-term fractal component of heart rate variability (beta) and the effect of an antianginal agent in patients with silent myocardial ischemia.
Takase B; Akima T; Satomura K; Ohsuzu F; Mastui T; Ishihara M; Kurita A
Biomed Pharmacother; 2004 Oct; 58 Suppl 1():S123-8. PubMed ID: 15754850
[TBL] [Abstract][Full Text] [Related]
6. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
Araki H; Hayata N; Nakamura M
Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
[TBL] [Abstract][Full Text] [Related]
7. Reduced heart rate variability in ischemic heart disease is only partially caused by ischemia. An HRV study before and after PTCA.
Wennerblom B; Lurje L; Solem J; Tygesen H; Udén M; Vahisalo R; Hjalmarson A
Cardiology; 2000; 94(3):146-51. PubMed ID: 11279319
[TBL] [Abstract][Full Text] [Related]
8. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
9. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon alpha treatment decreases heart rate variability indices and impairs exercise tolerance in patients with chronic hepatitis.
Takase B; Hamabe A; Uehata A; Hujioka T; Kondo T; Matsui T; Ohsuzu F; Ishihara M
Biomed Pharmacother; 2005 Oct; 59 Suppl 1():S163-8. PubMed ID: 16275487
[TBL] [Abstract][Full Text] [Related]
11. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
[TBL] [Abstract][Full Text] [Related]
12. [Changes in autonomic control of heart rate after ischemic cerebral stroke].
Lakusić N; Mahović D; Babić T; Sporis D
Acta Med Croatica; 2003; 57(4):269-73. PubMed ID: 14639860
[TBL] [Abstract][Full Text] [Related]
13. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
[TBL] [Abstract][Full Text] [Related]
14. Effects of bepridil on silent myocardial ischemia and eicosanoid metabolism in chronic stable angina pectoris after healing of myocardial infarction.
Takase B; Kurita A; Hikita H; Uehata A; Nishioka T; Maruyama T; Mizuno K; Nakamura H; Kanda Y
Am J Cardiol; 1994 Jun; 73(15):1063-8. PubMed ID: 8198031
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
[TBL] [Abstract][Full Text] [Related]
16. [Effects of nipradilol on the patients of angina pectoris: results from the study of the exercise electrocardiography using HR-ST loop method].
Maehara K; Morita M; Fukushima T; Sakurai K; Koseki Y; Takishima T
Kokyu To Junkan; 1993 Mar; 41(3):255-60. PubMed ID: 8097055
[TBL] [Abstract][Full Text] [Related]
17. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
18. Heart rate variability depression in patients with unstable angina.
Huang J; Sopher SM; Leatham E; Redwood S; Camm AJ; Kaski JC
Am Heart J; 1995 Oct; 130(4):772-9. PubMed ID: 7572585
[TBL] [Abstract][Full Text] [Related]
19. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease.
Panza JA; Diodati JG; Callahan TS; Epstein SE; Quyyumi AA
J Am Coll Cardiol; 1992 Nov; 20(5):1092-8. PubMed ID: 1401608
[TBL] [Abstract][Full Text] [Related]
20. Effect of nipradilol on cardiovascular hemodynamics during exercise in angina pectoris with old myocardial infarction.
Saito T; Sekiya T; Yamazaki Y; Makita K; Udaka Y; Inagaki Y
Arzneimittelforschung; 1992 Oct; 42(10):1195-9. PubMed ID: 1361735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
